menu
    • menu

    Company profile for Coya Therapeutics

    NEW Drugs in Dev: 8
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The company’s proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patie...
    The company’s proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson’s, Alzheimer’s, FTD and autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Coya TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5850 San Felipe St, Suite 500, Houston, Texas 77057
    Telephone
    Telephone
    1 (800) 587-8170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.coyatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/coya-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/CoyaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Coya Therapeutics Hosts ALS Drug Development Webinar
    Coya Therapeutics Hosts ALS Drug Development Webinar

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210471934/en/Coya-Therapeutics-to-Host-Webinar-with-Leading-Medical-Experts-on-Amyotrophic-Lateral-Sclerosis-ALS-Drug-Development-Patient-Landscape-and-Ongoing-Clinical-Trial

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Coya Therapeutics Announces $11.1 Million Private Placement
    Coya Therapeutics Announces $11.1 Million Private Placement

    30 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260130653717/en/Coya-Therapeutics-Announces-%2411.1-Million-Private-Placement

    BUSINESSWIRE
    30 Jan 2026
    Share Share
    Coya Therapeutics CEO Sends Letter To Stockholders
    Coya Therapeutics CEO Sends Letter To Stockholders

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120977124/en/Coya-Therapeutics-CEO-Dr.-Arun-Swaminathan-Issues-Letter-to-Stockholders

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Coya Therapeutics Reveals Study Results Showing Treg Boost
    Coya Therapeutics Reveals Study Results Showing Treg Boost

    08 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-08/coya-therapeutics-announces-results-of-investigator-initiated-study-of-ld-il-2-and-ctla4-ig-demonstr

    PHARMIWEB
    08 Jan 2026
    Share Share
    COYA Therapeutics' COYA 302 (IND) Accepted By U.S. FDA
    COYA Therapeutics' COYA 302 (IND) Accepted By U.S. FDA

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105080790/en/Coya-Therapeutics-Announces-U.S.-FDA-Acceptance-of-Investigational-New-Drug-IND-Application-for-COYA-302-for-the-Treatment-of-Frontotemporal-Dementia-FTD

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    COYA Therapeutics Gets Canada Approval For COYA 302 Trial
    COYA Therapeutics Gets Canada Approval For COYA 302 Trial

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223853357/en/Coya-Therapeutics-Receives-Clinical-Trial-Application-CTA-Acceptance-from-Health-Canada-to-Proceed-with-the-COYA-302-ALSTARS-Trial-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS

    BUSINESSWIRE
    23 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search